GSK invests hundreds of millions in vaccine firm backed by Bill, Melinda Gates
Drug giant GlaxoSmithKline is making a big bet on vaccines created around messenger RNA (mRNA) by investing hundreds of millions of dollars in CureVac, which also is backed by the Bill and Melinda Gates Foundation.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
